The U.S. plans to purchase from Pfizer and donate to Third World countries hundreds of millions of doses of the COVID vaccine, according to a story leaked to The
Washington Post.This is in addition to the more than 136 million doses already donated, according to the State Department. This is a great thing, right? No, it’s a travesty. The total global need is at least 13 billion doses. Back in May, President Biden did something worth celebrating. He authorized U.S. Trade Representative Katherine Tai to reverse the long-standing U.S. opposition to waiving the patent, copyright, and trademark protections of the WTO treaty known as TRIPS, to which the U.S. is a party. With that waiver, countries with vaccine manufacturing capacity, such as India, could produce the Pfizer vaccine at cost, at adequate quantities, and deliver it worldwide. But since that brave gesture, career U.S. trade officials based at WTO headquarters in Geneva have slow-rolled the TRIPS waiver, and there has been no progress at getting vaccines
actually produced in quantity. It is even more of a travesty if Pfizer, which has already made many billions in windfall COVID profits, is charging Uncle Sam, aka the U.S. taxpayer, any kind of a markup. In the leaked Post story, terms were not disclosed. The more the administration plays Pfizer’s game to purchase and donate what should be a public good, the more it plays into the drug industry’s hands and diverts public attention from the stalled TRIPS waiver. Meanwhile, Big Pharma uses its muscle to kill Biden’s plans for reduced prescription drug costs to Americans. Want to pay the drug companies back? Get the TRIPS waiver done.
Talking with the veteran organizer and Bernie Sanders campaign staffer about the quiet revolution that started a decade ago in Zuccotti Park BY DAVID DAYEN
All that public investment rebuilds infrastructure, greens the economy, and supports caregiving—but mainly it creates at least four million good jobs. BY ROBERT KUTTNER
The American Prospect IDEAS, POLITICS & POWER The American Prospect, Inc.
1225 I Street NW, Suite 600
Washington, DC xxxxxx
United States Copyright (C) 2021 The American Prospect. All rights reserved.
To opt out of American Prospect membership messaging, click here.
To manage your newsletter preferences, click here.
To unsubscribe from all American Prospect emails, including newsletters, click here.